Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil R Smith

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Hematology & Oncology|October 27, 2015
Complexity of FGFR signalling in metastatic urothelial cancerAlejo Rodriguez-Vida, Matilde Saggese, Simon Hughes, et al.
Molecular Cancer Therapeutics|March 19, 2008
Dual inhibition of VEGFR and EGFR signaling reduces the incidence and size of intestinal adenomas in Apc(Min/+) miceDenis Alferez, Robert W Wilkinson, Jim Watkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2010
Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancersNeil R Smith, Dawn Baker, Neil H James, et al.
Molecular Cancer Therapeutics|March 11, 2011
An antibody targeted to VEGFR-2 Ig domains 4-7 inhibits VEGFR-2 activation and VEGFR-2-dependent angiogenesis without affecting ligand bindingJane Kendrew, Cath Eberlein, Brad Hedberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2017
A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung CancersPaul K Paik, Ronglai Shen, Michael F Berger, et al.
Oncotarget|June 4, 2016
ATM protein is deficient in over 40% of lung adenocarcinomasLiza C Villaruz, Helen Jones, Sanja Dacic, et al.
Plos One|July 11, 2013
RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor CediranibJames R Bradford, Matthew Farren, Steve J Powell, et al.
Plos One|February 25, 2016
Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous AmpliconClaire Rooney, Catherine Geh, Victoria Williams, et al.
BMJ Open|September 1, 2012
The Olympic Regeneration in East London (ORiEL) study: protocol for a prospective controlled quasi-experiment to evaluate the impact of urban regeneration on young people and their familiesNeil R Smith, Charlotte Clark, Amanda E Fahy, et al.
Cell Metabolism|December 3, 2015
Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal CancerAurélien J C Pommier, Matthew Farren, Bhavika Patel, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Hematology & Oncology|October 27, 2015
Complexity of FGFR signalling in metastatic urothelial cancerAlejo Rodriguez-Vida, Matilde Saggese, Simon Hughes, et al.
Molecular Cancer Therapeutics|March 19, 2008
Dual inhibition of VEGFR and EGFR signaling reduces the incidence and size of intestinal adenomas in Apc(Min/+) miceDenis Alferez, Robert W Wilkinson, Jim Watkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2010
Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancersNeil R Smith, Dawn Baker, Neil H James, et al.
Molecular Cancer Therapeutics|March 11, 2011
An antibody targeted to VEGFR-2 Ig domains 4-7 inhibits VEGFR-2 activation and VEGFR-2-dependent angiogenesis without affecting ligand bindingJane Kendrew, Cath Eberlein, Brad Hedberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2017
A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung CancersPaul K Paik, Ronglai Shen, Michael F Berger, et al.
Oncotarget|June 4, 2016
ATM protein is deficient in over 40% of lung adenocarcinomasLiza C Villaruz, Helen Jones, Sanja Dacic, et al.
Plos One|July 11, 2013
RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor CediranibJames R Bradford, Matthew Farren, Steve J Powell, et al.
Plos One|February 25, 2016
Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous AmpliconClaire Rooney, Catherine Geh, Victoria Williams, et al.
BMJ Open|September 1, 2012
The Olympic Regeneration in East London (ORiEL) study: protocol for a prospective controlled quasi-experiment to evaluate the impact of urban regeneration on young people and their familiesNeil R Smith, Charlotte Clark, Amanda E Fahy, et al.
Cell Metabolism|December 3, 2015
Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal CancerAurélien J C Pommier, Matthew Farren, Bhavika Patel, et al.
Pageof 4